Frequently Asked Questions
Common Questions About Using ICD-10 Code B02.21 for Postherpetic geniculate ganglionitis
What are the common symptoms of Postherpetic geniculate ganglionitis?
Common symptoms include severe facial pain, facial weakness, and sensory abnormalities such as increased sensitivity or pain in the affected area, typically following a herpes zoster infection.
How is Postherpetic geniculate ganglionitis treated?
Treatment typically involves antiviral medications to reduce viral activity, pain management strategies, and supportive care such as physical therapy to improve function.
When should ICD-10 Code B02.21 be used?
ICD-10 Code B02.21 should be used when a patient presents with symptoms indicative of Postherpetic geniculate ganglionitis following a herpes zoster infection, ensuring accurate diagnosis and billing.
Is Postherpetic geniculate ganglionitis contagious?
No, Postherpetic geniculate ganglionitis itself is not contagious; however, the underlying varicella-zoster virus can be transmitted to individuals who have not had chickenpox or the vaccine.
